Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
4,450,764
-
Share change
-
+1,175,204
-
Total reported value
-
$7,963,000
-
Put/Call ratio
-
116%
-
Price per share
-
$1.79
-
Number of holders
-
25
-
Value change
-
+$2,116,276
-
Number of buys
-
14
-
Number of sells
-
7
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2021
As of 31 Mar 2021,
IGC Pharma, Inc. - COM NEW (IGC) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,450,764 shares.
The largest 10 holders included
BlackRock Inc., Davy Global Fund Management Ltd, VANGUARD GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Carroll Financial Associates, Inc., GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Vontobel Holding Ltd., DEARBORN PARTNERS LLC, and SIMPLEX TRADING, LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.